# Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial

Study · id `cardio:ct-nct01348438` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01348438](<https://clinicaltrials.gov/study/NCT01348438>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01348438

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

## Technical summary

Registry record NCT01348438. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09-12 (actual); primary completion 2013-02-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 125 participants (enrolled count; ClinicalTrials.gov record NCT01348438, source copy `cardio:ctgov-nct01348438-2018-09-18`, retrieved 2026-10-26)
- Started: 2011-09-12 (actual) (ClinicalTrials.gov record NCT01348438, source copy `cardio:ctgov-nct01348438-2018-09-18`, retrieved 2026-10-26)
- Primary completion: 2013-02-28 (actual) (ClinicalTrials.gov record NCT01348438, source copy `cardio:ctgov-nct01348438-2018-09-18`, retrieved 2026-10-26)
- Completion: 2018-01-25 (actual) (ClinicalTrials.gov record NCT01348438, source copy `cardio:ctgov-nct01348438-2018-09-18`, retrieved 2026-10-26)
- Countries: Belgium; Germany; Israel; Switzerland (ClinicalTrials.gov record NCT01348438, source copy `cardio:ctgov-nct01348438-2018-09-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01348438-2018-09-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
- Condition: Aortic Valve Stenosis
- Intervention (Device): Medtronic Engager Transcatheter Aortic Valve Implantation System
- Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

## Provenance

Content hash: 5db8d526bc38ce7efaab139e53b7b3b6ff749c8e8aab0b883b6369f22635752f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
